Menu
/REGISTER
Montecito
Tolman Wiker
Pac Premier
Fielding
Farmers merchants
Loading...
You are here:  Home  >  Biotech  >  Current Article

Judge rules for Amgen in patent dispute over Repatha competitor

By   /   Monday, February 25th, 2019  /   Comments Off on Judge rules for Amgen in patent dispute over Repatha competitor

    Print       Email
A jury handed Thousand Oaks-based Amgen a win in a long-running patent dispute against two of its competitors Feb. 25 over an alternative to its cholesterol treatment Repatha. The decision in a Delaware court upholds a previous jury ruling in 2016 against a competing drug developed by French multinational Sanofi and New York-based Regeneron called…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Santa Barbara’s Unity Shoppe closes and lays off 15 employees

Read More →